Stock market news today | Sensex, Nifty, share prices Key moves: BSE Sensex rose 130.18 points or 0.22% to 59,462.78 and NSE Nifty 50 rose 39.20 points or 0.22% to 17,698.20 mA.
Stock market news today | Sensex, Nifty, Equity Keys:
Indian benchmarks were near daily highs in a very turbulent period as the Nifty fell just below 17,700. The BSE Sensex rose 130.18 points or 0.22% to 59,462.78, The NSE Nifty 50 rose 39.20 points, or 0.22%, to 17,698.20. The oil and gas indexes rose 2.5%, while the metals and energy indices added 1.5% each. On the other hand, the Pharmaceutical Index fell 1% and Information Technology (IT) fell 0.76%. In the market, the BSE mid- and small-cap indexes rose. ONGC, Tata Steel, NTPC, UPL, and Power Grid Corp rose in growth, while Divis Lab, Apollo Hospitals, Infosys, Maruti Suzuki, and Tata Consumer Products lag.
Today at 17:30, the Department of Statistics and Program Implementation will publish data on price increases for July. According to economists, the increase in retail prices in July was caused by lower prices for food and other key commodities. In June, inflation measured by the consumer price index (CPI) fell to 7.01% from 7.04% in May. Last week, the RBI lowered its inflation target for July-September to 7.1% from 7.4% earlier.
Well the Sensex is a little ridiculously high
The BSE Sensex rose 130.18 points or 0.22% to 59,462.78, while the NSE Nifty 50 rose 39.20 points or 0.22% to 17,698.20. The oil and gas indexes rose 2.5%, while the metals and energy indices added 1.5% each. On the other hand, the Pharmaceutical Index fell 1% and Information Technology (IT) fell 0.76%.
Market integration is happening on a much larger scale; earnings are visible on BSE Midcap, BSE Smallcap
“Equity markets continued to perform well throughout the week. Major indices such as BSE-30 and Nifty-50 performed well this week. The market as a whole. Most global stock markets, continued their high momentum while the US CPI declined in July. Inside India saw the FPI perform well this week. As the 23-year economic season approaches, market focus will shift to major factors such as inflation, the Central Bank’s buying habit, the price of oil, and concerns about macroeconomics all over the world. the world.
GMDC’s first-quarter net income rose nine times year-over-year to Rs 345 crore.
GMDC reported nine-year net income growth to Rs 345 crore
as its quarterly net income rose 132% year on year to Rs 1,155 crore, helped by earnings from labor and wealth. revenue This was followed by a 95% increase in profits and a 9% increase in revenue.
Lupine receives USFDA approval, which is about 1%.
Lupine has received US Food and Drug Administration (FDA) approval for a new drug product (ANDA), USP meclizine hydrochloride tablets, 12.5mg, 25mg, and 50mg, 50mg to be marketed, for example, in Antivert tablets. 12.5 mg. , 25 mg and 50 mg manufactured by Casper Pharma LLC. The product is manufactured at the Lupine plant in Goa, India. Lupine closed at 683.70, down 6.20 or 0.90%.
Apollo hospitals fell 3%.
Apollo Hospitals fell 3% after a 35% year-on-year decline in net income in the first quarter.
Stock Market Awaits Impending Correction, Nifty Likely to Fall to 15,600 by Year End: BofA Securities